Reversible Left Bundle Branch Block Should Be Mentioned in Cardiac Resynchronization Therapy; a Clinical Case Report

Reversible Left Bundle Branch Block Should Be Mentioned in Cardiac Resynchronization Therapy; a Clinical Case Report

Vasheghanifarahani A¹ ; Tajdini M¹ ; Mohsenizadeh SA¹ ; Hosseini SMR²

Show Affiliations

1. Tehran Heart Center and Department of Cardiology, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Radiology, Massachusetts General Hospital, Boston, MI, United States

Source: ARYA Atherosclerosis Published:2016

Abstract

BACKGROUND: Cardiac resynchronization therapy (CRT) is a medical device to help cardiac synchronized contractility by electrical impulses. Improvement of symptoms and left ventricular systolic function, reducing hospital admissions and mortality in patients with moderate to severe heart failure are the main benefits of administration of cardiac resynchronization therapy. CASE REPORT: In this article, we describe a case of heart failure and left bundle branch block (LBBB) who was candidate for cardiac resynchronization therapy; but after managing hyperkalemia, left bundle branch block resolved, ejection fraction increased and cardiac resynchronization therapy implantation was canceled. CONCLUSION: Exclusion of treatable causes is the first important step before any interventions. Now there is an important question; is cardiac resynchronization therapy effective in patients with heart failure and transient or intermittent left bundle branch block?. © 2016, Isfahan University of Medical Sciences(IUMS). All rights reserved.

Style	Citing Format
MLA	Vasheghanifarahani A, et al.. "Reversible Left Bundle Branch Block Should Be Mentioned in Cardiac Resynchronization Therapy; a Clinical Case Report." ARYA Atherosclerosis, vol. 12, no. 3, 2016, pp. -.
APA	Vasheghanifarahani A, Tajdini M, Mohsenizadeh SA, Hosseini SMR (2016). Reversible Left Bundle Branch Block Should Be Mentioned in Cardiac Resynchronization Therapy; a Clinical Case Report. ARYA Atherosclerosis, 12(3), -.
Chicago	Vasheghanifarahani A, Tajdini M, Mohsenizadeh SA, Hosseini SMR. "Reversible Left Bundle Branch Block Should Be Mentioned in Cardiac Resynchronization Therapy; a Clinical Case Report." ARYA Atherosclerosis 12, no. 3 (2016): -.
Harvard	Vasheghanifarahani A et al. (2016) 'Reversible Left Bundle Branch Block Should Be Mentioned in Cardiac Resynchronization Therapy; a Clinical Case Report', ARYA Atherosclerosis, 12(3), pp. -.
Vancouver	Vasheghanifarahani A, Tajdini M, Mohsenizadeh SA, Hosseini SMR. Reversible Left Bundle Branch Block Should Be Mentioned in Cardiac Resynchronization Therapy; a Clinical Case Report. ARYA Atherosclerosis. 2016;12(3):-.
BibTex	@article{ author = {Vasheghanifarahani A and Tajdini M and Mohsenizadeh SA and Hosseini SMR}, title = {Reversible Left Bundle Branch Block Should Be Mentioned in Cardiac Resynchronization Therapy; a Clinical Case Report}, journal = {ARYA Atherosclerosis}, volume = {12}, number = {3}, pages = {-}, year = {2016} }
RIS	TY - JOUR AU - Vasheghanifarahani A AU - Tajdini M AU - Mohsenizadeh SA AU - Hosseini SMR TI - Reversible Left Bundle Branch Block Should Be Mentioned in Cardiac Resynchronization Therapy; a Clinical Case Report JO - ARYA Atherosclerosis VL - 12 IS - 3 SP - EP - PY - 2016 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract